Volkan Oezdemir Suspended for EPO Use

Violation Details

Former UFC title challenger Volkan Oezdemir has been hit with a 16‑month suspension after testing positive for erythropoietin (EPO). The suspension was announced following a positive result detected in February, according to the fighter’s own account. UFC officials confirmed the disciplinary action after consulting the World Anti‑Doping Agency (WADA) and Swiss authorities. The athlete, who holds a 21‑8 MMA and 9‑7 UFC record, will be eligible to compete again in June 2027 at age 37.

Impact on Career

The length of the ban effectively removes Oezdemir from the octagon for most of 2025 and well into 2026. By the time he can return, he will be 37, an age that already challenges the durability of even the most seasoned fighters. The interruption also impacts his standing among recent challengers for UFC titles. The UFC’s swift confirmation underscores the organization’s zero‑tolerance stance on performance‑enhancing drugs.

How It Happened

Oezdemir says a Swiss healthcare professional advised him to use the banned substance during recovery from an ankle injury. What began as a business arrangement shifted to a recovery protocol, with the practitioner claiming the injection would speed healing and remain undetectable. The fighter complied, calling it “the biggest mistake of my life.” He later cooperated fully with both the UFC and Combat Sports Anti‑Doping (CSAD) authorities.

Oezdemir’s Admission

In an Instagram statement, Oezdemir openly blamed his poor judgment and accepted full responsibility for the lapse. He described the moment his positive test was revealed on March 5 as a shattering of illusion and a turning point. The fighter emphasized that his cooperation with regulators was immediate and transparent. His contrition was paired with a pledge to learn from the experience.

Next Steps

The UFC confirmed that it reached out to WADA, prompting Swiss authorities to interview Oezdemir. All parties noted that the fighter maintained transparency throughout the investigation. Once the suspension ends in June 2027, Oezdemir will be free to pursue a return to competition. The case adds to the ongoing dialogue about medical guidance versus anti‑doping regulations in combat sports.